Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Breast Cancer | Research

BUN level is associated with cancer prevalence

Authors: Cai Wang, Hao Sun, Jin Liu

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Blood urea nitrogen (BUN) was an important biomarker for the development and prognosis of many diseases. Numerous studies had demonstrated that BUN had a strong relationship with long-term mortality, survival and the prevalence of some diseases. The diagnosis and treatment, prognosis and long-term survival rate of cancer were the focus of clinical research at present. However, the relationship between BUN level and cancer prevalence was not clear. To investigate the relationship between BUN level and cancer prevalence, we performed a statistical analysis of population data from the National Health and Nutrition Examination Survey (NHANES) database. The results of the study showed that BUN level were positively correlated with cancer prevalence, and the correlation was more pronounced in breast cancer.
Literature
1.
Beier K, Eppanapally S, Bazick HS, et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of “normal” creatinine. Crit Care Med. 2011;39(2):305–13.CrossRefPubMedPubMedCentral
2.
Lindenfeld J, Schrier RW. Blood urea nitrogen a marker for adverse effects of loop diuretics? J Am Coll Cardiol. 2011;58(4):383–5.CrossRefPubMed
3.
Du J, Niu J, Ma L, Sui Y, Wang S. Association between blood urea nitrogen levels and length of stay in patients with pneumonic chronic obstructive pulmonary disease exacerbation: a secondary analysis based on a multicentre, retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2022;17:2847–56.CrossRefPubMedPubMedCentral
4.
Chen CC, Hsieh JC, Chao CH, et al. Correlation between breath ammonia and blood urea nitrogen levels in chronic kidney disease and dialysis patients. J Breath Res. 2020;14(3):036002.CrossRefPubMed
5.
Lin SF, Teng HE, Lin HC. Blood urea nitrogen levels to verify estimated glomerular filtration rate, as derived from 2 commonly used equations. Lab Med. 2019;50(3):298–305.CrossRefPubMed
6.
Calice-Silva V, Sacomboio E, Raimann JG, Evans R, et al. Diagnostic performance of salivary urea nitrogen dipstick to detect and monitor acute kidney disease in patients with malaria. Malar J. 2018;17(1):477.CrossRefPubMedPubMedCentral
7.
Evans RDR, Hemmila U, Mzinganjira H, et al. Diagnostic performance of a point-of-care saliva urea nitrogen dipstick to screen for kidney disease in low-resource settings where serum creatinine is unavailable. BMJ Glob Health. 2020; 5(5):1.
8.
Xie Y, Bowe B, Li T, Xian H, Al-Aly Z. Blood urea nitrogen and risk of insulin use among people with diabetes. Diab Vasc Dis Res. 2018;15(5):409–16.CrossRefPubMed
9.
Jujo K, Minami Y, Haruki S, et al. Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure. ESC Heart Fail. 2017;4(4):545–53.CrossRefPubMedPubMedCentral
10.
Otto CM. Heartbeat: blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure. Heart. 2017;103(6):399–401.CrossRefPubMed
11.
Dundar ZD, Kucukceran K, Ayranci MK. Blood urea nitrogen to albumin ratio is a predictor of in-hospital mortality in older emergency department patients. Am J Emerg Med. 2021;46:349–54.CrossRefPubMed
12.
You S, Zheng D, Zhong C, et al. Prognostic significance of blood urea nitrogen in acute ischemic stroke. Circ J. 2018;82(2):572–8.CrossRefPubMed
13.
Hu B, Xu G, Jin X, et al. Novel prognostic predictor for primary pulmonary hypertension: focus on blood urea nitrogen. Front Cardiovasc Med. 2021;8:724179.CrossRefPubMedPubMedCentral
14.
15.
Zhao X, Wu X. Polycomb-group proteins in the initiation and progression of cancer. J Genet Genomics. 2021;48(6):433–43.CrossRefPubMed
16.
Undi RB, Filiberti A, Ali N, Huycke MM. Cellular carcinogenesis: role of polarized macrophages in cancer initiation. Cancers (Basel). 2022;14(11):1.
17.
Arshad Z, McDonald JF. Changes in gene–gene interactions associated with cancer onset and progression are largely independent of changes in gene expression. Science. 2021;24(12):103522.
18.
19.
Giuliani C. The flavonoid quercetin induces AP-1 activation in FRTL-5 thyroid cells. Antioxidants (Basel). 2019;8(5):1.
20.
Zhang Z, Wang M, Xu L, et al. Cancer occurrence following azathioprine treatment in myasthenia gravis patients: a systematic review and meta-analysis. J Clin Neurosci. 2021;88:70–4.CrossRefPubMed
21.
22.
23.
Han B, Gong M, Li Z, Qiu Y, Zou Z. NMR-based metabonomic study reveals intervention effects of polydatin on potassium oxonate-induced hyperuricemia in rats. Oxid Med Cell Longev. 2020;2020:6943860.CrossRefPubMedPubMedCentral
24.
Long H, Li J, Li R, et al. Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19. Epidemiol Infect. 2022;150:e106.CrossRefPubMed
25.
26.
Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):1.
27.
Gyamfi J, Kim J, Choi J. Cancer as a metabolic disorder. Int J Mol Sci. 2022;23(3):1.
28.
Sahoo OS, Pethusamy K, Srivastava TP, et al. The metabolic addiction of cancer stem cells. Front Oncol. 2022;12:1.
29.
Crocetto F, Russo G, Di Zazzo E, Pisapia P, Mirto BF, Palmieri A, Pepe F, Bellevicine C, Russo A, La Civita E, Terracciano D, Malapelle U, Troncone G, Barone B. Liquid biopsy in prostate cancer management-current challenges and future perspectives. Cancers (Basel). 2022;14(13):1.
30.
Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L. Role of FGFR3 in bladder cancer: treatment landscape and future challenges. Cancer Treat Rev. 2023;115:102530.CrossRefPubMed
31.
Yu Y, Gong L, Ye J. The role of aberrant metabolism in cancer: insights into the interplay between cell metabolic reprogramming, metabolic syndrome, and cancer. Front Oncol. 2020;10:942.CrossRefPubMedPubMedCentral
32.
Fakhri S, Moradi SZ, Farzaei MH, Bishayee A. Modulation of dysregulated cancer metabolism by plant secondary metabolites: a mechanistic review. Semin Cancer Biol. 2022;80:276–305.CrossRefPubMed
33.
Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218(1):1.
34.
35.
Liu C, Zhao Q, Yu X. Bone marrow adipocytes, adipocytokines, and breast cancer cells: novel implications in bone metastasis of breast cancer. Front Oncol. 2020;10:561595.CrossRefPubMedPubMedCentral
36.
Rybinska I, Agresti R, Trapani A, Tagliabue E, Triulzi T. Adipocytes in breast cancer, the thick and the thin. Cells. 2020;9(3):1.
37.
Zhang F, Liu S. Mechanistic insights of adipocyte metabolism in regulating breast cancer progression. Pharmacol Res. 2020;155:104741.CrossRefPubMed
38.
Liang L, Sun F, Wang H, Hu Z. Metabolomics, metabolic flux analysis and cancer pharmacology. Pharmacol Ther. 2021;224:107827.CrossRefPubMed
39.
Gentile F, La Civita E, Della Ventura B, Ferro M, Cennamo M, Bruzzese D, Crocetto F, Velotta R, Terracciano D. A combinatorial neural network analysis reveals a synergistic behaviour of multiparametric magnetic resonance and prostate health index in the identification of clinically significant prostate cancer. Clin Genitourin Cancer. 2022;20(5):e406–10.CrossRefPubMed
40.
Di Lorenzo G, Buonerba L, Ingenito C, Crocetto F, Buonerba C, Libroia A, Sciarra A, Ragone G, Sanseverino R, Iaccarino S, Napodano G, Imbimbo C, Leo E, Kozlakidis Z, De Placido S. Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy. Oncology. 2020;98(10):743–7.CrossRefPubMed
Metadata
Title
BUN level is associated with cancer prevalence
Authors
Cai Wang
Hao Sun
Jin Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01186-4

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Research

Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders

Review

Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis

Review

TGF-β promotes the proliferation and osteogenic differentiation of dental pulp stem cells a systematic review and meta-analysis

Research

Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series

Research

Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)

Research

Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?